Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Harvard Medical School, and Division of Immunology, Boston Children’s Hospital, Boston, Massachusetts.
Mol Cancer Ther (2024) 23 (10): 1365.
A $6.4 billion lawsuit against Bristol Myers Squibb (BMS) was dismissed on Monday. The suit alleged that BMS purposely delayed approval of drugs developed by Celgene to avoid paying $6.4 billion to ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
Goodman Cancer Institute, McGill University, Montréal, Canada.
Division of Hematology/Oncology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York. Department of Systems Biology, ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
The University of Texas MD Anderson Cancer Center, Houston, TX, United States ...
Major Finding: Coagulation factor X (FX) promotes proliferation and androgen independence in prostate cancer. Concept: Immunosuppressive neutrophils secrete FX, which binds PAR2 on PCa cells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback